Abcellera Biologics Inc
NASDAQ:ABCL
Wall Street
Price Targets
ABCL Price Targets Summary
Abcellera Biologics Inc
According to Wall Street analysts, the average 1-year price target for ABCL is 15.68 USD with a low forecast of 8.08 USD and a high forecast of 29.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is ABCL's stock price target?
Price Target
15.68
USD
According to Wall Street analysts, the average 1-year price target for ABCL is 15.68 USD with a low forecast of 8.08 USD and a high forecast of 29.4 USD.
What is Abcellera Biologics Inc's Revenue forecast?
Projected CAGR
30%
For the last 4 years the compound annual growth rate for Abcellera Biologics Inc's revenue is 35%. The projected CAGR for the next 3 years is 30%.